Literature DB >> 30363866

The Clinical Spectrum of Ataxia with Oculomotor Apraxia Type 2.

Florian Brugger1, Michael Schüpbach2, Michel Koenig3,4, René Müri5, Stephan Bohlhalter5,6, Alain Kaelin-Lang2, Christian P Kamm5, Georg Kägi1.   

Abstract

Ataxia with oculomotor apraxia type 2 (AOA2) is an inherited disorder caused by mutations within both alleles of the senataxin gene. First symptoms are usually recognized before the age of 30. Unlike several other autosomal recessive cerebellar ataxia syndromes, levels of alpha-fetoprotein are nearly always elevated in AOA2 and thus narrowing down the differential diagnosis list. We present 3 video cases illustrating and expanding the clinical spectrum of AOA2, with 1 case bearing a novel mutation with cervical dystonia as the first symptom, the absence of neuropathy, and a disease onset beyond the age of 40. Furthermore, all patients were assessed by oculographic analysis, which revealed distinct patterns of oculomotor abnormalities. The clinical spectrum of AOA2 might be even broader than previously described in larger series. Oculography might be a useful tool to detect subclinical oculomotor apraxia in this disorder.

Entities:  

Keywords:  AOA2; ataxia; oculomotor apraxia; senataxin

Year:  2014        PMID: 30363866      PMCID: PMC6183195          DOI: 10.1002/mdc3.12021

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  13 in total

1.  Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study.

Authors:  C Criscuolo; L Chessa; S Di Giandomenico; P Mancini; F Saccà; G S Grieco; M Piane; F Barbieri; G De Michele; S Banfi; F Pierelli; N Rizzuto; F M Santorelli; L Gallosti; A Filla; C Casali
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

Review 2.  The autosomal recessive cerebellar ataxias.

Authors:  Mathieu Anheim; Christine Tranchant; Michel Koenig
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

Review 3.  Clinical features and molecular genetics of autosomal recessive cerebellar ataxias.

Authors:  Brent L Fogel; Susan Perlman
Journal:  Lancet Neurol       Date:  2007-03       Impact factor: 44.182

4.  Ataxia with oculomotor apraxia type 2: a clinical and genetic study of 19 patients.

Authors:  M Tazir; L Ali-Pacha; A M'Zahem; J P Delaunoy; M Fritsch; S Nouioua; T Benhassine; S Assami; D Grid; J M Vallat; A Hamri; M Koenig
Journal:  J Neurol Sci       Date:  2009-01-11       Impact factor: 3.181

5.  Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management.

Authors:  M Anheim; M Fleury; B Monga; V Laugel; D Chaigne; G Rodier; E Ginglinger; C Boulay; S Courtois; N Drouot; M Fritsch; J P Delaunoy; D Stoppa-Lyonnet; C Tranchant; M Koenig
Journal:  Neurogenetics       Date:  2009-05-14       Impact factor: 2.660

6.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

7.  Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients.

Authors:  M Anheim; B Monga; M Fleury; P Charles; C Barbot; M Salih; J P Delaunoy; M Fritsch; L Arning; M Synofzik; L Schöls; J Sequeiros; C Goizet; C Marelli; I Le Ber; J Koht; J Gazulla; J De Bleecker; M Mukhtar; N Drouot; L Ali-Pacha; T Benhassine; M Chbicheb; A M'Zahem; A Hamri; B Chabrol; J Pouget; R Murphy; M Watanabe; P Coutinho; M Tazir; A Durr; A Brice; C Tranchant; M Koenig
Journal:  Brain       Date:  2009-08-20       Impact factor: 13.501

8.  Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients.

Authors:  Isabelle Le Ber; Naïma Bouslam; Sophie Rivaud-Péchoux; João Guimarães; Ali Benomar; Céline Chamayou; Cyril Goizet; Maria-Ceù Moreira; Sandra Klur; Mohamed Yahyaoui; Yves Agid; Michel Koenig; Giovanni Stevanin; Alexis Brice; Alexandra Dürr
Journal:  Brain       Date:  2004-01-21       Impact factor: 13.501

9.  Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2.

Authors:  Maria-Céu Moreira; Sandra Klur; Mitsunori Watanabe; Andrea H Németh; Isabelle Le Ber; José-Carlos Moniz; Christine Tranchant; Patrick Aubourg; Meriem Tazir; Lüdger Schöls; Massimo Pandolfo; Jörg B Schulz; Jean Pouget; Patrick Calvas; Masami Shizuka-Ikeda; Mikio Shoji; Makoto Tanaka; Louise Izatt; Christopher E Shaw; Abderrahim M'Zahem; Eimear Dunne; Pascale Bomont; Traki Benhassine; Naïma Bouslam; Giovanni Stevanin; Alexis Brice; João Guimarães; Pedro Mendonça; Clara Barbot; Paula Coutinho; Jorge Sequeiros; Alexandra Dürr; Jean-Marie Warter; Michel Koenig
Journal:  Nat Genet       Date:  2004-02-08       Impact factor: 38.330

10.  Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination.

Authors:  Konstantina Skourti-Stathaki; Nicholas J Proudfoot; Natalia Gromak
Journal:  Mol Cell       Date:  2011-06-24       Impact factor: 17.970

View more
  2 in total

1.  Late-onset ataxia plus syndromes: Extending the phenotype of senataxin-related disease.

Authors:  Duncan Street; Mary O'Driscoll; Malcolm Taylor; David Nicholl
Journal:  Neurol Clin Pract       Date:  2020-06

2.  Autosomal recessive adult onset ataxia.

Authors:  Nataša Dragašević-Mišković; Iva Stanković; Andona Milovanović; Vladimir S Kostić
Journal:  J Neurol       Date:  2021-09-09       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.